Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate.
Mult Scler. 2021 Mar;27(3):439-448. doi: 10.1177/1352458520918489. Epub 2020 May 28.
Mult Scler. 2021.
PMID: 32463336
Comparative analysis of natalizumab versus fingolimod as second-line treatment in relapsing-remitting multiple sclerosis.
Lorscheider J, Benkert P, Lienert C, Hänni P, Derfuss T, Kuhle J, Kappos L, Yaldizli Ö.
Lorscheider J, et al. Among authors: hanni p.
Mult Scler. 2018 May;24(6):777-785. doi: 10.1177/1352458518768433. Epub 2018 Apr 24.
Mult Scler. 2018.
PMID: 29685071
Item in Clipboard
Influence of age at disease onset on future relapses and disability progression in patients with multiple sclerosis on immunomodulatory treatment.
von Wyl V, Décard BF, Benkert P, Lorscheider J, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, Yaldizli Ö.
von Wyl V, et al. Among authors: hanni p.
Eur J Neurol. 2020 Jun;27(6):1066-1075. doi: 10.1111/ene.14191. Epub 2020 Apr 3.
Eur J Neurol. 2020.
PMID: 32097512
Item in Clipboard
Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis.
Lorscheider J, Benkert P, Lienert C, Hänni P, Derfuss T, Kuhle J, Kappos L, Yaldizli Ö.
Lorscheider J, et al. Among authors: hanni p.
J Neurol. 2021 Mar;268(3):941-949. doi: 10.1007/s00415-020-10226-6. Epub 2020 Sep 24.
J Neurol. 2021.
PMID: 32974794
Free PMC article.
Item in Clipboard
Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis.
Müller J, Schädelin S, Lorscheider J, Benkert P, Hänni P, Schmid J, Kuhle J, Derfuss T, Granziera C, Yaldizli Ö.
Müller J, et al. Among authors: hanni p.
Eur J Neurol. 2023 Dec;30(12):3809-3818. doi: 10.1111/ene.16044. Epub 2023 Aug 29.
Eur J Neurol. 2023.
PMID: 37578431
Item in Clipboard
Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis.
Müller J, Roos I, Kalincik T, Lorscheider J, Galli E, Benkert P, Schädelin S, Sharmin S, Einsiedler M, Hänni P, Schmid J, Kuhle J, Derfuss T, Granziera C, Ziemssen T, Siepmann T, Yaldizli Ö.
Müller J, et al. Among authors: hanni p.
Brain Behav. 2024 May;14(5):e3498. doi: 10.1002/brb3.3498.
Brain Behav. 2024.
PMID: 38688877
Free PMC article.
Item in Clipboard
How the forebrain transitions to adulthood: developmental plasticity markers in a long-lived rodent reveal region diversity and the uniqueness of adolescence.
Garduño BM, Hanni P, Hays C, Cogram P, Insel N, Xu X.
Garduño BM, et al. Among authors: hanni p.
Front Neurosci. 2024 Feb 22;18:1365737. doi: 10.3389/fnins.2024.1365737. eCollection 2024.
Front Neurosci. 2024.
PMID: 38456144
Free PMC article.
Item in Clipboard
Vocal cord dysfunction: an important differential diagnosis of brittle asthma.
Borer H, Hänni P, Schoenenberger RA.
Borer H, et al. Among authors: hanni p.
Respiration. 2001;68(3):318. doi: 10.1159/000050517.
Respiration. 2001.
PMID: 11416255
No abstract available.
Item in Clipboard
Cite
Cite